X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36) 36
humans (35) 35
oncology (29) 29
male (21) 21
middle aged (18) 18
cancer (16) 16
female (15) 15
aged (13) 13
adult (11) 11
chemotherapy (11) 11
metastasis (11) 11
transplantation (11) 11
hematology (10) 10
prostate cancer (10) 10
survival (10) 10
treatment outcome (10) 10
apoptosis (9) 9
tumors (9) 9
urology & nephrology (9) 9
animals (8) 8
kidney neoplasms - pathology (8) 8
retrospective studies (8) 8
urology (8) 8
carcinoma, renal cell - pathology (7) 7
medicine & public health (7) 7
antineoplastic agents - therapeutic use (6) 6
apoptosis - drug effects (6) 6
care and treatment (6) 6
hematology, oncology and palliative medicine (6) 6
immunology (6) 6
mutation (6) 6
prognosis (6) 6
sunitinib (6) 6
surgery (6) 6
targeted therapy (6) 6
analysis (5) 5
inhibition (5) 5
leukemia (5) 5
metastases (5) 5
molecular targeted therapy (5) 5
neoplasm metastasis (5) 5
renal cell cancer (5) 5
research paper (5) 5
antibodies (4) 4
antineoplastic agents - pharmacology (4) 4
article (4) 4
cancer research (4) 4
carcinoma (4) 4
carcinoma, renal cell - genetics (4) 4
cell line, tumor (4) 4
disease-free survival (4) 4
docetaxel (4) 4
enzalutamide (4) 4
expression (4) 4
gene (4) 4
increased survival (4) 4
interferon-alpha (4) 4
kidney neoplasms - surgery (4) 4
met (4) 4
mitoxantrone (4) 4
patient outcomes (4) 4
prednisone (4) 4
prospective studies (4) 4
renal cell carcinoma (4) 4
resistance (4) 4
therapy (4) 4
versus-host-disease (4) 4
adolescent (3) 3
aged, 80 and over (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
antithymocyte globulin (3) 3
bcl-2 (3) 3
biochemistry & molecular biology (3) 3
cancer-cells (3) 3
carcinoma, renal cell - surgery (3) 3
carcinoma, renal cell - therapy (3) 3
cell biology (3) 3
clonal evolution (3) 3
diseases (3) 3
double-blind (3) 3
enzymes (3) 3
fas ligand (3) 3
gene expression (3) 3
genetic aspects (3) 3
immunohistochemistry (3) 3
kidney neoplasms - genetics (3) 3
lymphocytes (3) 3
medical research (3) 3
multidisciplinary sciences (3) 3
myelodysplastic syndromes - therapy (3) 3
neoplasm grading (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
pathways (3) 3
patients (3) 3
phase-iii trial (3) 3
prostate (3) 3
prostatic neoplasms - metabolism (3) 3
protein (3) 3
rabbits (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Recent Results in Cancer Research, ISSN 0080-0015, 2018, Volume 211, pp. 67 - 75
Cabozantinib is a receptor tyrosine kinase inhibitor (TKI) with activity against a broad range of targets, including MET, RET, AXL, VEGFR2, FLT3, and c-KIT.... 
Renal cell cancer | Multikinase-Inhibitor | AXL | MET | Medullary thyroid cancer
Journal Article
Der Onkologe, ISSN 0947-8965, 06/2019, Volume 25, Issue 6, pp. 482 - 482
Journal Article
Der Onkologe, ISSN 0947-8965, 06/2019, Volume 25, Issue 6, p. 482
Journal Article
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, ISSN 0080-0015, 2014, Volume 201, pp. 207 - 214
Journal Article
Der Onkologe, ISSN 0947-8965, 11/2016, Volume 22, Issue 11, pp. 886 - 888
Journal Article
Recent Results in Cancer Research, ISSN 0080-0015, 2018, Volume 211, pp. 187 - 198
Lenvatinib is an oral receptor tyrosine kinase inhibitor (TKI) with activity against vascular endothelial growth factor (VEGF) receptors 1-3, fibroblast growth... 
Hepatocellular carcinoma | Lenvantinib | Differntiated thyroid cancer | Renal cell carcinoma
Journal Article
Journal Article
Der Onkologe, ISSN 0947-8965, 06/2019, Volume 25, Issue 6, pp. 480 - 481
Journal Article
Der Onkologe, ISSN 0947-8965, 11/2016, Volume 22, Issue 11, p. 886
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00761-016-0096-3 
Tyrosine
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 07/2018, Volume 45, Issue 7, pp. 535 - 538
A 19‐year‐old man suffering from testicular choriocarcinoma presented to the dermatology department with a cutaneous metastasis on his head. This metastasis... 
syncytiotrophoblasts | cytotrophoblasts | cutaneous metastases | testicular choricarcinoma | TESTIS | SKIN | PATHOLOGY | OF-THE-LITERATURE | DERMATOLOGY | Choriocarcinoma | Chorionic gonadotropin | Metastasis | Liver | Pituitary (anterior) | Gonadotropins | Neurosurgery | Lymph nodes | Metastases | Chemotherapy | Computed tomography | Biopsy | Scalp | Uvea | Skin | Testes | Tumors
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2014, Volume 14, Issue 1, pp. 350 - 350
Journal Article
Oncology Letters, ISSN 1792-1074, 04/2019, Volume 17, Issue 4, pp. 3890 - 3898
Recently, a tumor-autonomous cytochrome P450 (CYP)-3A5-mediated resistance to cancer therapy has been demonstrated in pancreatic ductal adenocarcinoma.... 
Immunohistochemistry | Resistance | Irinotecan | Colorectal adenoma | RECIST | Colorectal cancer | Cytochrome P450 3A5 | CYTOCHROME-P450 | colorectal cancer | irinotecan | MANAGEMENT | XENOBIOTIC-METABOLIZING ENZYMES | RISK | COLON | TOXICITY | resistance | colorectal adenoma | POLYMORPHISMS | THERAPY | ONCOLOGY | P450 | immunohistochemistry
Journal Article
Der Onkologe, ISSN 0947-8965, 06/2019, Volume 25, Issue 6, p. 480
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 4574 - 10
Journal Article
Nature Communications, ISSN 2041-1723, 06/2016, Volume 7, Issue 1, p. ncomms11845
Intratumoural heterogeneity (ITH) is a major cause of cancer-associated lethality. Extensive genomic ITH has previously been reported in clear cell renal cell... 
MULTIFOCAL PROSTATE-CANCER | GENETIC-VARIATION | INSTABILITY | VARIANTS | MULTIDISCIPLINARY SCIENCES | METASTASES | CLONAL EVOLUTION | DIVERSITY | E-CADHERIN | TUMORS | RENAL-CELL CARCINOMA
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.